Staphylococcal Resistance Patterns, blaZ and SCC mec Cassette Genes in the Nasopharyngeal Microbiota of Pregnant Women.
Sylwia AndrzejczukMonika CyganDominik Franciszek DłuskiDagmara Stępień-PyśniakUrszula KosikowskaPublished in: International journal of molecular sciences (2023)
Antimicrobial resistance in Staphylococcus spp. colonising the nasopharynx can create risk factors of therapeutic treatment failure or prophylaxis in pregnant women. Resistance is mostly encoded on plasmids (e.g., blaZ gene for penicillinase synthesis) or chromosomes (e.g., mecA and mecC for methicillin resistance). The mecA gene is part of the chromosomal mec gene cassette (SCC mec ), which is also located on the plasmid. The disc diffusion method for the selected drugs (beta-lactams, fluoroquinolones, streptogramins, aminoglicosides, macrolides, oxasolidinones, tetracyclines and other groups) was used. PCR for blaZ , mecA and mecC genes and SCC mec cassette detection and typing were performed. S. aureus (54.4%) and S. epidermidis (27.9%) were the most prevalent and showed the highest diversity of resistance profiles. The blaZ, mecA and mecC genes were reported in 95.6%, 20.6% and 1.5% of isolates, respectively. The highest resistance was found to beta-lactams, commonly used during pregnancy. Resistance to a variety of antimicrobials, including benzylpenicillin resistance in blaZ -positive isolates, and the existence of a very high diversity of SCC mec cassette structures in all staphylococci selected from the nasopharyngeal microbiota of pregnant women were observed for the first time. Knowledge of the prevalence of antimicrobial-resistant staphylococci in the nasopharynx of pregnant women may be important for the appropriate treatment or prophylaxis of this group of patients.
Keyphrases
- pregnant women
- genome wide
- antimicrobial resistance
- staphylococcus aureus
- risk factors
- genome wide identification
- copy number
- escherichia coli
- end stage renal disease
- dna methylation
- healthcare
- gene expression
- mass spectrometry
- chronic kidney disease
- crispr cas
- newly diagnosed
- peritoneal dialysis
- combination therapy
- transcription factor
- genome wide analysis
- real time pcr
- candida albicans
- cystic fibrosis